The Protein Research Study

The study is exploring a first in human drug which is hoped to be a new potential treatment for Netherton Syndrome (NS), a rare genetic disorder that affects the skin, hair, and immune system.

The purpose of the study is to understand the study drug’s disposition in the body, which includes how it is absorbed, distributed, metabolized, and excreted. This insight is crucial for determining the most optimal dosage and for advancing the medication to later stages of clinical development.

Call us on 1300 517 998 to discuss your eligibility today!